Last reviewed · How we verify
KETOPROFEN LYSINE
At a glance
| Generic name | KETOPROFEN LYSINE |
|---|---|
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Abdominal pain
- Ligament sprain
- Dizziness
- Muscle injury
- Dyspepsia
- Nausea
- Toothache
- Chest discomfort
- Fatigue
- Injection site erythema
- Injection site irritation
- Injection site rash
Key clinical trials
- A Study on Ketoprofen Lysine Salt (KLS) + Gabapentin (GABA) vs KLS to Investigate Their Pharmacodynamic in Healthy Males (PHASE1)
- A Study to Assess Efficacy and Tolerability of Ketoprofen 40 mg Granules vs Placebo (PHASE3)
- Crossover, Single Dose Randomized, Bioequivalence of Ketoprofen Lysine Salt Immediate Release vs Oral Solution (PHASE1)
- Bioequivalence of Ketoprofen Oral Gel vs Ketoprofen Lysine Salt as Granules for Oral Solution (PHASE1)
- Ketoprofen Lysine Salt as Mouthwash in Acute Phlogosis of the Pharyngeal Cavity Versus Benzidamine Hydrochloride (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KETOPROFEN LYSINE CI brief — competitive landscape report
- KETOPROFEN LYSINE updates RSS · CI watch RSS